Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Asthma
Interventions: Drug: Indacaterol dose; Drug: Placebo; Drug: Salmeterol
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Condition: Exercise Induced Asthma
Interventions: Drug: Budesonide/Formoterol; Drug: Budesonide
Sponsors: Children's Hospital Boston; Brigham and Women's Hospital
Recruiting - verified February 2010
Condition: Asthma
Intervention:
Sponsors: University of California, San Francisco; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Asthma
Intervention: Other: Quest for the Code
Sponsors: Winthrop University Hospital; Asthma Coalition of Long Island
Recruiting - verified February 2010
Condition: Chronic Plaque-type Psoriasis
Interventions: Drug: AIN457; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Placebo; Drug: Tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified March 2010
Condition: Asthma
Intervention: Other: Computerized Asthma Management System
Sponsor: Vanderbilt University
Not yet recruiting - verified February 2010
Condition: Perennial Allergic Rhinitis
Intervention: Drug: ciclesonide HFA 160 μg
Sponsor: Sepracor, Inc.
Recruiting - verified February 2010
Condition: Chronic Urticaria
Interventions: Drug: Placebo; Drug: Hydroxychloroquine
Sponsor: Vanderbilt University
Not yet recruiting - verified February 2010
Conditions: Asthma; Chronic Sinusitis
Interventions: Procedure: Endoscopic Sinus Surgery; Other: medical therapy
Sponsor: NorthShore University HealthSystem Research Institute
Recruiting - verified February 2010
Condition: Asthma
Interventions: Drug: Albuterol DPI; Drug: Albuterol MDI; Drug: Placebo HFA MDI and Placebo DPI
Sponsor: Teva Global Respiratory Research LLC
Recruiting - verified February 2010
Condition: Allergic Rhinitis
Interventions: Drug: Fluticasone Furoate Nasal Spray; Drug: Olopatadine Nasal Spray; Drug: Saline Nasal Spray
Sponsor: ORA, Inc.
Not yet recruiting - verified February 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Device: placebo; Drug: Fluticasone Furoate (FF)/GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: QAX028; Drug: QAX028; Drug: Tiotropium; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - verified February 2010
Condition: Enteritis
Intervention: Drug: DOR201 (delayed release beclomethasone dipropionate)
Sponsors: Soligenix; National Cancer Institute (NCI)
Recruiting - verified February 2010
Condition: Asthma
Interventions: Dietary Supplement: Fish Oil; Dietary Supplement: Ascorbic Acid; Dietary Supplement: Fish Oil Placebo; Dietary Supplement: Ascorbic Acid Placebo
Sponsor: Indiana University
Recruiting - verified March 2010
Condition: Hereditary Angioedema
Intervention:
Sponsor: Dyax Corp.
Recruiting - verified February 2010
Condition: Influenza
Interventions: Drug: Nitazoxanide; Drug: Placebo
Sponsor: Romark Laboratories L.C.
Recruiting - verified February 2010
Conditions: Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease
Interventions: Drug: FF/GW642444 Inhalation Powder; Drug: Placebo; Drug: FF Inhalation Powder; Drug: GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease
Interventions: Drug: FF Inhalation Powder; Drug: FF/GW642444 Inhalation Powder; Drug: GW642444 Inhalation Powder; Drug: Placebo
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: aclidinium bromide/formoterol fumarate combination; Drug: aclidinium bromide/formoterol fumarate combination; Drug: aclidinium bromide; Drug: formoterol fumarate; Drug: placebo
Sponsors: Forest Laboratories; Almirall, S.A.
Recruiting - verified February 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Olodaterol (BI1744) Low; Drug: Olodaterol (BI1744) High; Drug: Tiotropium 18 mcg; Drug: Placebo (for Olodatero (BI1744)l); Drug: Placebo (for Tiotropium)
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: AMG 853; Drug: AMG 853; Drug: AMG 853; Drug: AMG 853; Drug: Placebo
Sponsor: Amgen
Recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: Fluticasone Furoate/GW642444; Drug: Fluticasone propionate
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF/GW642444 Inhalation Powder; Drug: GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Combivent Respimat; Drug: Combivent CFC-MDI; Drug: Atrovent HFA + Albuterol HFA
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Asthma
Intervention: Biological: Mepolizumab (treatment) - Severe asthma
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Metastatic Castration-Resistant Prostate Cancer
Intervention: Drug: dextromethorphan hydrobromide or theophylline
Sponsor: Cougar Biotechnology, Inc.
Recruiting - verified February 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GW642444 Inhalation Powder; Drug: FF/GW642444 Inhalation Powder
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Veramyst /Artificial tears; Drug: Veramyst / Artificial tears lubricant eye drops; Drug: Veramyst nasal spray and Olopatadine eye drops; Other: Veramyst placebo and Olopatadine0.2% eye drops
Sponsors: University of Chicago; GlaxoSmithKline
Recruiting - verified November 2009
Condition: Asthma
Interventions: Drug: ABT-308; Drug: ABT-308; Drug: Placebo; Drug: Placebo
Sponsor: Abbott
Recruiting - verified January 2010
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Fluticasone propionate/salmeterol combination product; Drug: Salmeterol; Drug: Placebo
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Asthma
Interventions: Biological: MEDI-528; Biological: MEDI-528; Biological: MEDI-528; Other: Placebo
Sponsor: MedImmune LLC
Recruiting - verified March 2010
Condition: Allergic Rhinitis
Interventions: Drug: Ibuprofen; Drug: Fluticasone propionate; Drug: Placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Asthma
Intervention: Drug: JNJ39758979
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified February 2010
Condition: Asthma
Interventions: Drug: QMF149 Twisthaler®; Drug: Mometasone Twisthaler®
Sponsor: Novartis Pharmaceuticals
Recruiting - verified March 2010
Condition: Amblyopia
Interventions: Drug: Atropine; Device: Plano lens; Drug: Atropine
Sponsors: Jaeb Center for Health Research; National Eye Institute (NEI)
Recruiting - verified October 2009
Conditions: HIV; Asthma
Interventions: Drug: Darunavir; Drug: Ritonavir; Drug: Beclomethasone Dipropionate HFA
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified July 2009
Conditions: Deglutition Disorders; Esophageal Diseases; Eosinophilia
Intervention: Other: assessment of disease activity using the EEsAI
Sponsors: University Hospital Inselspital, Berne; Institute of Social and Preventive Medicine, University Bern; Dept. of Gastroenterology, Kantonsspital Olten, Olten; Institute for Pathology, Kantonsspital Lucerne, Lucerne; Mayo Clinic Rochester, Minnesota, USA; University of Cincinnati; University of Colorado, Denver; Northwestern University of Chicago, Illinois, USA; Indiana University School of Medicine; Philadelphia University
Not yet recruiting - verified March 2010
Conditions: Acute Otitis Media; Chronic Otitis Media; Recurrent Acute Otitis Media
Intervention: Device: Iontophoresis System (Acclarent)
Sponsor: Acclarent
Recruiting - verified March 2010
Condition: Bronchopulmonary Dysplasia
Interventions: Drug: Inhaled Nitric Oxide; Drug: Placebo
Sponsor: INO Therapeutics
Recruiting - verified March 2010
Conditions: Hereditary Angioedema; C1 Esterase Inhibitor Deficiency
Intervention: Biological: C1 inhibitor (human)
Sponsor: ViroPharma
Recruiting - verified August 2009
Condition: Hereditary Angioedema
Interventions: Drug: Icatibant; Drug: Placebo
Sponsors: Jerini AG; Shire Human Genetic Therapies, Inc.
Recruiting - verified November 2009
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Arformoterol; Drug: Placebo
Sponsor: Sepracor, Inc.
Recruiting - verified February 2010
Condition: Pulmonary Hypertension
Intervention: Drug: UT-15C
Sponsor: United Therapeutics
Recruiting - verified February 2010
Conditions: Idiopathic Pulmonary Fibrosis; Pulmonary Hypertension
Intervention: Drug: Ambrisentan or placebo
Sponsor: Gilead Sciences
Recruiting - verified March 2010
Condition: Allergic Airway Disease
Intervention: Drug: Broccoli sprout extract
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Condition: Fecal Incontinence
Interventions: Drug: Clonidine; Drug: Placebo; Drug: Atropine; Drug: Normal saline
Sponsor: Mayo Clinic
Recruiting - verified February 2010
Conditions: Chronic Sinusitis; Chronic Rhinosinusitis; Nasal Polyps
Intervention: Drug: Prednisone
Sponsor: Northwestern University
Recruiting - verified February 2010
Condition: Asthma
Interventions: Drug: Levalbuterol; Drug: Levalbuterol UDV TID; Drug: Placebo
Sponsor: Sepracor, Inc.
Recruiting - verified February 2010
Condition: Psoriasis Vulgaris
Intervention: Drug: Calcipotriene plus betamethasone dipropionate ointment
Sponsor: LEO Pharma
Recruiting - verified March 2010
Conditions: Rhinitis; Allergic Conjunctivitis
Interventions: Biological: 6 Amb a 1-U; Biological: 12 Amb a 1-U; Biological: Placebo
Sponsor: Schering-Plough
Recruiting - verified February 2010
Condition: Atopic Asthma
Interventions: Drug: abatacept; Drug: Placebo
Sponsors: Washington University School of Medicine; Bristol-Myers Squibb
Recruiting - verified February 2010
Condition: Asthma
Interventions: Drug: tiotropium 5mcg/day; Drug: tiotropium 5mcg/day
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: tiotropium 5mcg/day; Drug: tiotropium 5mcg/day
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified March 2010
Conditions: Rhinitis; Allergic Conjunctivitis
Interventions: Biological: 1.5 Amb a 1-U; Biological: 6 Amb a 1-U; Biological: 12 Amb a 1-U; Biological: Placebo
Sponsor: Schering-Plough
Recruiting - verified February 2010
Condition: Bronchopulmonary Dysplasia
Intervention:
Sponsor: University of Utah
Recruiting - verified February 2010
Condition: Asthma
Intervention: Dietary Supplement: Soy Isoflavone
Sponsors: Northwestern University; Respiratory Health Association of Metropolitan Chicago
Recruiting - verified February 2010
Conditions: Chronic Obstructive Pulmonary Disease; Sleep Disorders
Intervention: Drug: salmeterol-fluticasone
Sponsors: Northwestern University; GlaxoSmithKline
Recruiting - verified February 2010
Condition: Eosinophilic Esophagitis
Interventions: Drug: Nexium; Drug: Pulmicort Respules and Splenda
Sponsors: Mayo Clinic; AstraZeneca
Recruiting - verified February 2010
Condition: Cancer
Interventions: Drug: montelukast sodium; Other: flow cytometry; Other: laboratory biomarker analysis; Procedure: quality-of-life assessment
Sponsor: National Cancer Institute (NCI)
Recruiting - verified August 2008
Condition: Bronchiolitis
Interventions: Drug: Fluticasone Propionate; Other: Observation
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified March 2010
Condition: Bronchiolitis
Intervention:
Sponsors: Connecticut Children's Medical Center; University of Connecticut Health Center
Recruiting - verified February 2010
Condition: Inflammatory Disorder
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Condition: Exercise-induced Bronchoconstriction (EIB)
Interventions: Drug: Comparator: montelukast sodium; Drug: Comparator: Comparator: placebo (unspecified)
Sponsor: Merck
Recruiting - verified March 2010
Condition: Atopic Dermatitis
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Eosinophilic Esophagitis
Interventions: Drug: Montelukast/ Singulair; Drug: Placebo
Sponsors: Mayo Clinic; Merck
Recruiting - verified February 2010
Conditions: Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: beclomethasone dipropionate; Drug: methotrexate; Drug: tacrolimus; Other: placebo
Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI)
Recruiting - verified July 2009
Condition: Atopic Dermatitis
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Pulmonary Hypertension
Interventions: Drug: Oral treprostinil (UT-15C) Sustained Release Tablets; Other: Placebo
Sponsor: United Therapeutics
Recruiting - verified March 2010
Conditions: Brain Death; Organ Donor; Pulmonary Edema
Interventions: Drug: Albuterol; Drug: Saline
Sponsors: Vanderbilt University; California Transplant Donor Network; University of California, San Francisco
Recruiting - verified February 2010
Condition: Allergic Asthma
Interventions: Drug: Omalizumab; Drug: Placebo for Omalizumab; Drug: omalizumab
Sponsors: Creighton University; Genentech
Recruiting - verified February 2010
Condition: Hypersensitivity, Immediate
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2009
Condition: Asthma
Interventions: Drug: omalizumab; Drug: placebo
Sponsor: Genentech
Recruiting - verified February 2010
Conditions: Cystic Fibrosis; Sarcoidosis; Tuberous Sclerosis; Asthma
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2010
All Categories ... by Medical Condition » ... Asthma » ... United States 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
